Bio-Techne Diagnostics at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Bio-Techne Diagnostics brings 1 presentation to AMP 2026 in Seattle, and exhibits at Booth 737, 837. Its session covers measurable residual disease testing in blood cancers, weighing deep sensitivity against practical laboratory workflow. The company supplies amplification-based enrichment and long-read sequencing products to clinical labs and assay developers.
| Organization | AMP 2026 Attendance |
|---|---|
Bio-Techne Diagnostics Austin, TX | |
Supplies clinical labs and assay developers with amplification-based enrichment and long-read sequencing products for genetic and oncology testing. | Booth Exhibiting at Booth 737, 837 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 11:00am–11:50am Deep Sensitivity Meets Workflow Efficiency: Optimizing HemOnc MRD Testing in Your Laboratory Quantitative PCR for myeloid residual disease, including laboratory experience validating a new PML-RARA kit and its workflow. |
Instantly find 20 buyers from Bio-Techne Diagnostics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction